Emily Titus
About Emily Titus
Emily Titus: Senior Vice President of Technical Operations
Emily Titus serves as the Senior Vice President, Technical Operations at Notch Therapeutics. Her role encompasses overseeing and optimizing technical processes and systems to enhance the company's operational efficacy. Her extensive background in gene regulatory networks and embryonic stem cell research informs her strategic approach to technical challenges in biotechnology.
Emily Titus' Education and Expertise
Emily Titus completed her Ph.D. at the Institute of Biomaterials and Biomedical Engineering at the University of Toronto. Her doctoral research involved using a combination of laboratory and bioinformatics approaches to define and interpret gene regulatory networks that control embryonic stem cell fate decisions. This expertise significantly contributes to her leadership and innovation in the field of biotechnology.
Emily Titus' Professional Background
Before joining Notch Therapeutics, Emily Titus was the Vice President of Technology Advancement at the Centre for Commercialization of Regenerative Medicine (CCRM). In this role, she was instrumental in fostering technological innovations and advancing the commercialization of regenerative medicines. Her efforts include building critical programs in cell reprogramming, genome engineering, and pluripotent stem cell differentiation at CCRM.
Emily Titus' Role in Forming Notch Therapeutics
Emily Titus played a key role in the formation of Notch Therapeutics. She led the company's development as part of CCRM's company incubation program, contributing her extensive experience in biotechnology to establish and grow the organization. Her work has been pivotal in setting the foundation for Notch Therapeutics' innovative approaches in the biotech industry.